Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 86.70
-1.40 (-1.59%)
Jul 31, 2026, 4:08 PM HKT
Innovent Biologics Stock Forecast
Stock Price Forecast
According to 29 analysts polled by S&P Global, Innovent Biologics stock has a consensus rating of "Strong Buy" and an average price target of $117.50. The average 1-year stock price forecast is 35.52% higher than the current stock price, while the lowest is $83.39 (-3.82%) and the highest is $139.99 (+61.46%).
Price Target: $117.50 (+35.52%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Innovent Biologics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 21 | 21 | 22 | 22 | 22 | 22 |
| Buy | 4 | 5 | 5 | 6 | 6 | 6 |
| Hold | 3 | 3 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 28 | 29 | 29 | 30 | 29 | 29 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst UOB Kay Hian No rating | UOB Kay Hian | Buy Maintains $112.00 | Buy | Maintains | $112.00 | +29.18% | Jul 16, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $139.90 | Buy | Maintains | $139.90 | +61.36% | Jul 15, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $124.00 → $124.10 | Buy | Maintains | $124.00 → $124.10 | +43.14% | Jul 14, 2026 |
Unknown Analyst Zhongtai Securities No rating | Zhongtai Securities | Buy Maintains $134.50 | Buy | Maintains | $134.50 | +55.13% | Jul 11, 2026 |
Unknown Analyst HSBC No rating | HSBC | Buy Maintains $120.00 | Buy | Maintains | $120.00 | +38.41% | Jul 10, 2026 |
Financial Forecast
Revenue This Year
18.56B
from 13.04B
Increased by 42.30%
Revenue Next Year
22.18B
from 18.56B
Increased by 19.52%
EPS This Year
1.32
from 0.99
Increased by 33.05%
EPS Next Year
1.98
from 1.32
Increased by 50.48%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.